[In vitro evaluation on the effects of combined lamivudine (3TC) and Ara-AMP against hepatitis B virus]

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Mar;16(1):16-9.
[Article in Chinese]

Abstract

Background: To evaluate the inhibitive effect of combination of 3TC with Ara-AMP against HBV in vitro.

Methods: Used 2.2.15 cell as target cell. With radioimmunological technique and blot slot, the inhibitive effect of 3TC, Ara-AMP and the combination of both against the HBsAg, HBeAg and intracellular HBV DNA were investigated.

Results: The inhibitive ratio of Ara-AMP against HBsAg, HBeAg was 45.48% and 41.46% respectively when its concentration was 400.0 microgram/ml. Although 3TC also has inhibitive effect in its experimental concentration, its effect is weaker. When Ara-AMP 50.0 microgram/ml was combined with 3TC 1.25 and 5.00 microgram/ml respectively, the inhibitive ratio against HBsAg were 19.92% and 17.32% respectively. Compared with using same concentration 3TC alone, the difference of results was significant (P<0.05). But when compared with using the same concentration Ara-AMP alone, the difference of results had no statistical significance (P <0.05). Remarkable inhibitive effects of combination of 3TC with Ara-AMP against HBeAg were n ot found. When 3TC 5.00 microgram/ml was combined with Ara-AMP 12.5 and 50.0 microgram/ml respectively, the inhibitive ratio against HBV DNA was 45.90% and 50.36% respectively. Comparing the content of HBV DNA in these groups with that of control group and the groups using the same concentration 3TC and Ara-AMP alone, the differences were significant (P <0.05).

Conclusions: Combination of 3TC with Ara-AMP could enhance the inhibitive effects against HBV DNA.

Publication types

  • English Abstract

MeSH terms

  • Antiviral Agents / pharmacology*
  • DNA, Viral / drug effects
  • DNA, Viral / metabolism
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Hepatitis B virus / drug effects*
  • Humans
  • In Vitro Techniques
  • Lamivudine / pharmacology*
  • Vidarabine Phosphate / pharmacology*

Substances

  • Antiviral Agents
  • DNA, Viral
  • Vidarabine Phosphate
  • Lamivudine